Hillstream BioPharma, Inc., a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, provided a business review along with key pipeline updates.
February 14, 2022
· 9 min read